top of page
Publications
[136] A First-In-Human Phase 1 Study to Evaluate the Safety and Tolerability of LEM-S401, a Novel siRNA-DegradaBALL Drug Targeting CTGF in Healthy Adults
Ha-Yeon Kim, Jaeso Cho, Min Kyu Park, Dal-Hee Min*, Jun Gi Hwang*, and Cheolhee Won*, CTS-Clin. Transl. Sci. 2025, 18(4), e70207 (Published date : 31 May 2025)
[130] Metabolic Modulation of Kynurenine Based on Kynureninase-Loaded Nanoparticle Depot Overcomes Tumor Immune Evasion in Cancer Immunotherapy
Se-Youl Chae, Hojeong Shin, Jiwon Woo, Seounghun Kang, Soo Min Lee, and Dal-Hee Min*, ACS Appl. Mater. Interfaces 2024, 16, 15, 18490–18502 (Published date : 04 Apr 2024)
[125] Rod-to-sphere elemental reconstruction of biocompatible Ag2Te–Ag4.53–Te3 nanoparticles for triple negative breast cancer photo-nano-therapy
Hojung Ahn, Seounghun Kang, Kyungtae Kang, Do Nam Lee, Dal-Hee Min* and Hongje Jang*, J. Mater. Chem. B, 2023, 11, 5142-5150 (Published date : 13 May 2023)
bottom of page